Philippe Schaison
CIK 1637140 · EVP, President Allergan Med · last filed 2025-11-17
Philippe Schaison is an EVP, President Allergan Med who has filed 11 SEC Form 4 insider transactions across 4 companies since 2015. The most recent filing, for SKIN, was dated Nov 17, 2025. Across all open-market trades the lifetime net is +$100.0K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $397.8K across reported positions. 3 SEC filings were submitted jointly with Actavis plc.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
SIEN price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
400 INTERPACE PARKWAY
PARSIPPANY, NJ 07054
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SKIN | Director | 2,885 | $0.55 | $1.6K | $0 | 1 | 2025-11-17 |
| Sientra, Inc. (SIEN) Delisted | Director | 22,736 | $0.17 | $4.0K | $100.0K | 8 | 2023-06-20 |
| Allergan plc (AGN) Delisted | EVP, President Allergan Med | 8,620 | — | — | $0 | 1 | 2016-06-08 |
| ACT | See Remarks | 8,620 | $45.97 | $396.3K | $0 | 1 | 2015-03-19 |
Recent Filings
11 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-11-17 | SKIN | Grant (A) | +57,692 | $0 | EDGAR |
| 2023-06-20 | Sientra, Inc. (SIEN) Delisted | Grant (A) | +12,000 | $0 | EDGAR |
| 2022-06-13 | Sientra, Inc. (SIEN) Delisted | Grant (A) | +103,306 | $0 | EDGAR |
| 2021-06-15 | Sientra, Inc. (SIEN) Delisted | Grant (A) | +23,936 | $0 | EDGAR |
| 2020-06-09 | Sientra, Inc. (SIEN) Delisted | Grant (A) | +27,717 | $0 | EDGAR |
| 2019-06-18 | Sientra, Inc. (SIEN) Delisted | Grant (A) | +19,320 | $0 | EDGAR |
| 2018-06-07 | Sientra, Inc. (SIEN) Delisted | Grant (A) | +6,116 | $125.0K | EDGAR |
| 2018-05-09 | Sientra, Inc. (SIEN) Delisted | Buy (P) | +7,407 | $100.0K | EDGAR |
| 2017-06-26 | Sientra, Inc. (SIEN) Delisted | Grant (A) | +12,861 | $125.0K | EDGAR |
| 2016-06-08 | Allergan plc (AGN) Delisted | — | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.